Hoʻomoʻo Isatuximab-irfc

Anter

• Ma mua o ka loaʻa ʻana o ka injection isatuximab-irfc,
• Hoʻokumu paha ka hopena ʻo Isatuximab-irfc i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

Hoʻohana ʻia ka injection Isatuximab-irfc me pomalidomide (Pomalyst) a me dexamethasone e mālama i nā myeloma he nui (kahi ʻano maʻi ʻaʻai o ka iwi iwi) i nā mākua i loaʻa i ʻelua mau lāʻau ʻē aʻe, e like me ka lenalidomide (Revlimid) a me kahi mea hoʻohālua proteasome e like me bortezomib (Velcade) a i ʻole carfilzomib (Kyprolis). Aia ʻo Isatuximab-irfc injection i kahi papa o nā lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ke kōkua ʻana i ke kino e hoʻolohi a kū i ka ulu ʻana o nā hunaola maʻi ʻaʻai.

ʻO Isatuximab-irfc injection e hele mai ma ke ʻano he hopena (wai) e injected intravenously (i loko o kahi aa koko) e ke kauka a kahu hānai paha. I ka mua, hāʻawi pinepine ʻia ia ma nā lā 1, 8, 15, a me 22 o ka pōʻaiapuni 28 mau lā mua. Ma hope o ka pōʻaiapuni mua, hāʻawi mau ʻia ia ma nā lā 1 a me 15 o ka pōʻaiapuni 28 mau lā. Hiki ke hana hou i kēia pōʻaiapau ke hoʻomau ka hana ʻana o ka lāʻau lapaʻau a ʻaʻole kumu ʻia nā hopena ʻino.

E nānā pono kahi kauka a kahu hānai paha iā ʻoe ke loaʻa nei ka infusion a ma hope o ka hoʻopili ʻana e ʻike pono ʻaʻole ʻoe i kahi hopena koʻikoʻi i ka lāʻau. Hāʻawi ʻia ʻoe i nā lāʻau ʻē aʻe e kōkua e pale aku i nā hopena i ka isatuximab-irfc. E haʻi koke i kāu kauka a kahu hānai paha inā ʻike ʻoe i kekahi o nā ʻōuli e hiki ke hana ʻia i ka wā o ka infusion a i ʻole 24 mau hola ma hope o kou loaʻa ʻana o ka infusion: nausea, ka hanu ʻole, ka uha, a me ka haʻalulu.

Kāohi paha kāu kauka i kahi manawa a kūloko paha i kāu lāʻau. Aia kēia i ka maikaʻi o ka hana ʻana o ka lāʻau iā ʻoe a me nā hopena ʻē aʻe āu e ʻike ai. E haʻi pono i kāu kauka i kou ʻano i kou wā e mālama ai me isatuximab-irfc.

E noi i kāu kauka lāʻau a kauka paha no kahi kope o ka ʻike a ka mea hana no ka mea maʻi.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka loaʻa ʻana o ka injection isatuximab-irfc,

• e haʻi i kāu kauka a me ka kauka inā he maʻi ʻoe i ka isatuximab-irfc, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka inikū isatuximab-irfc. E noi i kāu kauka lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa ʻoe i kahi maʻi.
• e haʻi i kāu kauka inā hāpai ʻoe a i ʻole hoʻolālā e hāpai. Pono ʻoe e hoʻohana i ka kaohi hānau e pale ai i ka hāpai ʻana i ka wā o kāu mālama ʻana me ka inikū isatuximab-irfc a no 5 mau mahina ma hope o kāu hopena hope loa. E kamaʻilio me kāu kauka e pili ana i nā ʻano hana hānau hiki iā ʻoe ke hoʻohana. Inā hāpai ʻoe i ka loaʻa ʻana o ka inikū isatuximab-irfc, e kāhea i kāu kauka. Hoʻopilikia paha ʻo Isatuximab-irfc i ke fetus.
• e haʻi i kāu kauka inā e hānai ana ʻoe i ka waiū. E haʻi paha kāu kauka iā ʻoe ʻaʻole e hānai i ka waiū i kou wā e mālama ai me isatuximab-irfc.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā haʻalele ʻoe i kahi manawa e loaʻa ai ka isatuximab-irfc, e kāhea koke i kāu kauka.

Hoʻokumu paha ka hopena ʻo Isatuximab-irfc i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• pāhoehoe
• nausea
• ka luaʻi

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

• ke anu, ka puʻu ʻeha, ke kuni, a me ka ʻūhā; ʻeha a puhi paha i ka urination; aiʻole nā ​​hōʻailona ʻē aʻe o ka maʻi
• kahe ʻole ke kahe ʻana, palū maʻalahi, a i ʻole ke koko ʻulaʻula i nā noho
• ka pōkole o ka hanu, ka liko a i ʻole ka nāwaliwali, a i ʻole ka ʻili pale

Hiki i ka Isatuximab-irfc ke hoʻonui i kou makaʻu i ka hoʻomohala ʻana i nā maʻi ʻē aʻe. E kamaʻilio me kāu kauka e pili ana i ka makaʻu o ka loaʻa ʻana o kēia lāʻau.

Hiki i ka Isatuximab-irfc ke kumu i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka loaʻa ʻana o kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E kauoha paha kāu kauka i kekahi mau hoʻokolohua lab e nānā i ka pane o kou kino i ka inikū isatuximab-irfc.

Ma mua o ka hoʻāʻo ʻana i kahi keʻena hoʻokolohua, e haʻi i kāu kauka a me nā limahana o ke keʻena hoʻokolohua āu e loaʻa nei i ka inikū isatuximab-irfc.

E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka inikū isatuximab-irfc.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Sarclisa^®